We're the national organization providing support, resources, volunteer opportunities and hope for people fighting pancreatic ...
PanCAN Chief Scientific and Medical Officer Anna Berkenblit discusses how PanCAN supports all patients diagnosed with ...
Michele Wood started volunteering with the Boston Affiliate in 2010. She had lost her dad to pancreatic cancer in 2007, and soon began looking for ways to change the disease’s low survival rate and ...
Since 2003, we have awarded 240 grants to 220 scientists at 78 institutions and our total projected research investment is approximately $208 million, including our competitive Research Grants Program ...
In 1999, when the Pancreatic Cancer Action Network (PanCAN) was founded, there were only a handful of scientists focused on pancreatic cancer, and research funding opportunities were scarce. Today, ...
Pancreatic cancer remains one of the most challenging cancers to prevent, diagnose or treat. Its risk factors and symptoms are unfamiliar to most. And with no standard test to find pancreatic cancer ...
When there was no one for patients with pancreatic cancer and their families to turn to, we built this community to ensure no one has to face this disease alone. For 26 years, we’ve stood up to one ...
With No Standard Early Detection Test for the General Public, Leading Nonprofit Dedicated to Advancing Progress Encourages ...
The types of cancer people are getting and dying from most may be changing in the next 20 years, according to a new study. Published today in JAMA Network Open, PanCAN and our research partners at ...
For the third year in the row, the five-year survival rate for pancreatic cancer has increased one percentage point, according to the American Cancer Society’s Cancer Facts & Figures 2024 Report ...
FDA Approves New First-line Treatment Option for Metastatic Pancreatic Cancer: What You Need to Know
For the first time in more than a decade, the FDA has approved a new first-line treatment for patients with metastatic pancreatic cancer. After a clinical trial showed a positive survival benefit, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results